Publications

Research publications supported and funded by the project (KPI)

• Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: focus on miR-363-3p and promoter methylation, Monika Drobna-Śledzińska, Natalia Maćkowska-Maślak, Roman Jaksik, Maria Kosmalska, Bronisława Szarzyńska, Monika Lejman, Łukasz Sędek, Tomasz Szczepański, Tom Taghon, Pieter Van Vlierberghe, Michał Witt, Małgorzata Dawidowska, Genes, Chromosomes and Cancer, doi: 10.1002/gcc.23085, Zenodo.

Other publications in the field of hemato-oncology co-authored by researchers from the project consortium

• Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B cell lymphomas. Cristina López, Nikolai Schleussner, Stephan H. Bernhart, Kortine Kleinheinz, Stephanie Sungalee, Henrike L. Sczabiel, Helene Kretzmer, Umut H. Toprak, Selina Glaser, Rabea Wagener, Ole Ammerpohl, Susanne Bens, Maciej Giefing, Juan C. González Sánchez, Gordana Apic, Daniel Hübschmann, Martin Janz, Markus Kreuz, Anja Mottok, Judit M. Müller, Julian Seufert, Steve Hoffmann, Jan O. Korbel, Robert B. Russell , Roland Schüle, Lorenz Trümper, Wolfram Klapper, Bernhard Radwimmer, Peter Lichter, ICGC MMML-Seq Consortium, Ralf Küppers, Matthias Schlesner, Stephan Mathas, and Reiner Siebert, Haematologica. 2022 Apr 28. doi: 10.3324/haematol.2021.280005, doi: 10.3324/haematol.2021.280005,

• Loss of function mutations of BCOR in classical Hodgkin lymphoma. Giefing M, Gearhart MD, Schneider M, Overbeck B, Klapper W, Hartmann S, Ustaszewski A, Weniger MA, Wiehle L, Hansmann ML, Melnick A, Beguelin W, Sundrom Ch, Kuppers R, Bardwell VJ, Siebert R, Leukemia and Lymphoma, 2022, 63 (5): 1080-1090, doi: 10.1080/10428194.2021.2015587, IF-3,280

• The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma. Ziel-Swier LJYM, Liu Y, Seitz A, de Jong D, Koerts J, Rutgers B, Veenstra R, Razak FRA, Dzikiewicz-Krawczyk A van den Berg A and Kluiver J, Genes, 2022, 13(2) 227, doi.10.3390/genes13020227, IF-4,096

• Enhancing B-Cell Malignancies-On Repurposing Enhancer Activity towards Cancer. Kasprzyk ME, Sura W, Dzikiewicz-Krawczyk A, Cancers (MDPI), 2021 Jun 29;13(13) e3270,  https://doi:10.3390/cancers13133270, IF-6,639

• 7-[[(4-methyl-2-pyridinyl)amino](2-pyridinyl)methyl]-8-quinolinol (compound 30666) inhibits enhancer activity and reduces B-cell lymphoma growth – A question of specificity, Kasprzyk ME, Łosiewski W, Podralska M, Kazimierska M, Sura W, Dzikiewicz-Krawczyk A, Eur J Pharmacol, 2021 Sep 14; 910, art. 174505. doi: 10.1016/j.ejphar.2021.174505, IF-4,432

• RNA-seq library preparation for comprehensive transcriptome analysis in cancer cells, Jaksik R, Drobna-Śledzińska M and Dawidowska M, Genomics, 2021 Nov, 11 (6): 4149-62, Epub Nov 3, doi.10.1016/j.ygeno.2021.10.018, doi.org/10.1016/j.ygeno.2021.10.018, IF-5,736

• DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning, Maćkowska N, Drobna-Śledzńska M, Witt M and Dawidowska M, Int J Mol Sci, Special Issue “Epigenetic Mechanisms and Human Pathology (MDPI), 2021, e1388, https://doi.org/10.3390/ijms22031388, IF-5,923

• Deregulated miRNAs contribute to silencing of B-cell specific transcription factors and activation of NF-κB in classical Hodgkin lymphoma, Paczkowska J, Janiszewska J, Ustaszewski A, Beim J, Skalski M, Dzikiewicz-Krawczyk A, Rozwadowska N, Hannsmann M-L, Hartman S. Giefing M, Cancers, 2021, 13 (13), e3131; doi: 10.3390/cancers13133131, IF-6,639